Within the European Medicines Agency (the ‘Agency’),this Regulation provides for a framework for and the means of:
(a)
preparing for, preventing, coordinating and managing the impact of public health emergencies on medicinal products and on medical devices and the impact of major events on medicinal products and on medical devices at Union level;
(b)
monitoring, preventing, and reporting on shortages of medicinal products and on shortages of medical devices;
(c)
setting up an interoperable information technology (IT) platform at Union level to monitor and report on shortages of medicinal products;
(d)
providing advice on medicinal products that have the potential to address public health emergencies;
(e)
providing support for the expert panels provided for in Article 106(1) of Regulation (EU) 2017/745.